Optimizing patient selection for prostate monotherapy
- 1 March 2001
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 49 (3) , 673-677
- https://doi.org/10.1016/s0360-3016(00)01421-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Clinical Utility of the Percentage of Positive Prostate Biopsies in Defining Biochemical Outcome After Radical Prostatectomy for Patients With Clinically Localized Prostate CancerJournal of Clinical Oncology, 2000
- THE PERCENT OF CORES POSITIVE FOR CANCER IN PROSTATE NEEDLE BIOPSY SPECIMENS IS STRONGLY PREDICTIVE OF TUMOR STAGE AND VOLUME AT RADICAL PROSTATECTOMYJournal of Urology, 2000
- Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapyInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1998
- Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinomaCancer, 1998
- Prostate Specific Antigen Based Disease Control Following Ultrasound Guided sup 125 Iodine Implantation for Stage T1/T2 Prostatic CarcinomaJournal of Urology, 1995
- Free, Complexed and Total Serum Prostate Specific Antigen: The Establishment of Appropriate Reference Ranges for their Concentrations and RatiosJournal of Urology, 1995